XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating expenses:        
Research and development $ 11,149,136 $ 10,454,072 $ 35,175,531 $ 40,055,287
General and administrative 11,859,702 12,238,566 29,639,951 36,817,686
Total operating expenses 23,008,838 22,692,638 64,815,482 76,872,973
Loss from operations (23,008,838) (22,692,638) (64,815,482) (76,872,973)
Other (expenses) income:        
Interest/investment income, net 856,478 1,321,441 2,875,379 3,892,478
Realized (loss) gain on short-term investments 147,835 (51,714) 334,082 (718,422)
Unrealized (loss) gain on short-term investments 278,555 (579,147) 283,803 72,329
Total other (expense) income – net 1,282,868 690,580 3,493,264 3,246,385
Net loss $ (21,725,970) $ (22,002,058) $ (61,322,218) $ (73,626,588)
Loss per common share – basic (in Dollars per share) $ (0.72) $ (0.73) $ (2.03) $ (2.45)
Loss per common share –diluted (in Dollars per share) $ (0.72) $ (0.73) $ (2.03) $ (2.45)
Weighted average number of common shares outstanding – basic (in Shares) 30,174,202 30,099,203 30,160,242 30,099,203
Weighted average number of common shares outstanding – diluted (in Shares) 30,174,202 30,099,203 30,160,242 30,099,203